Subscribe or Manage Preferences
Rheumatology Practice Management February 2017 Vol 5 No 1 - From the Editor
Ethel D. Owen, Editor-in-Chief
Editor-in-Chief Rheumatology Practice Management
Immediate Past President, NORM

In the past year, we have seen a number of changes in the world of rheumatology practice management, and with a new administration in the White House and healthcare policy reform remaining a top priority among lawmakers, there is no doubt that more changes are on the horizon. A significant triumph at the end of 2016 was the repeal of the controversial Medicare Part B Demonstration Project, which was originally introduced as a way to cut Medicare Part B drug costs. This project was a 5-year pilot program that would have impacted rheumatology practices across the nation by reducing Part B drug reimbursement. One of the main concerns among medical organizations and patient advocacy groups was that the Centers for Medicare & Medicaid Services had overstepped its authority and failed to engage stakeholders in a decision that could affect millions of patients and clinicians.

Fortunately, the medical community quickly recognized the deficiencies of the proposal and its negative consequences regarding access to care for the Medicare population. A strong advocacy effort across numerous specialties ensued and we witnessed the formal withdrawal of the Part B Demonstration Project on December 15, 2016.

The National Organization of Rheumatology Managers (NORM) would like to acknowledge the efforts of organizations such as the Coalition of State Rheumatology Organizations, the National Infusion Center Association, the Community Oncology Alliance, and the American College of Rheumatology for their unwavering resistance to the Medicare Part B Demonstration Project. Although it was a difficult battle, it was encouraging to see the power of advocacy in action.

An important challenge moving forward will be to stay vigilant regarding new legislative and regulatory proposals aimed at addressing the high costs of Part B medications, and to ensure that the voices of patients, clinicians, and other healthcare professionals continue to be heard.

In the coming year, NORM and Rheumatology Practice Management will strive to provide practice managers with the information and resources they need to deliver quality patient care.

Related Items
Reflections on a Successful Year
Andrea Zlatkus
Rheumatology Practice Management December 2017 Vol 6 No 5 published on January 8, 2018 in From the Editor
Announcing Andrea Zlatkus as President of NORM
Ethel D. Owen, Editor-in-Chief
Rheumatology Practice Management October 2017 Vol 5 No 5 published on October 20, 2017 in From the Editor
Are You Ready for the NORM Annual Conference?
Ethel D. Owen, Editor-in-Chief
Rheumatology Practice Management August 2017 Vol 5 No 4 published on August 16, 2017 in From the Editor
New Alliance Formed to Address Drug Pricing and Transparency Issues
Ethel D. Owen, Editor-in-Chief
Rheumatology Practice Management June 2017 Vol 5 No 3 published on June 28, 2017 in From the Editor
Expert Coding Advice Coming to Rheumatology Practice Management
Ethel D. Owen, Editor-in-Chief
Rheumatology Practice Management April 2017 Vol 5 No 2 published on April 25, 2017 in From the Editor
Let Your Voice Be Heard: Medicare Part B
Ethel D. Owen, Editor-in-Chief
Rheumatology Practice Management June 2016 Vol 4 No 3 published on June 30, 2016 in From the Editor
Announcing Ethel Owen as Editor-in-Chief of Rheumatology Practice Management
Iris Nichols
Rheumatology Practice Management February 2016 Vol 4 No 1 published on March 10, 2016 in From the Editor
Dramatic Reimbursement Changes Coming: SGR Is Out and MACRA Is In, but It Will Not Be Easy for Practices
Dawn Holcombe, MBA, FACMPE, ACHE
Oncology Practice Management - December 2015, Vol 5, No 9 published on December 22, 2015 in From the Editor
Making the Grade in Oncology Care
Dawn Holcombe, MBA, FACMPE, ACHE
Oncology Practice Management - November 2015, Vol 5, No 8 published on November 11, 2015 in From the Editor
ICD-10 Is Here—Now What?
Dawn Holcombe, MBA, FACMPE, ACHE
Oncology Practice Management - October 2015, Vol 5, No 7 published on October 13, 2015 in From the Editor
Last modified: March 30, 2017
  • American Health and Drug Benefits
  • Lynx CME
  • Value Based Care in Rheumatology
  • Oncology Practice Management
  • Urology Practice Management

Search